| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | CA2112466A1 Methods and compositions for diagnosing lyme disease |
| 01/07/1993 | CA2112112A1 Hormone-secreting cells maintained in long-term culture |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | CA2093790A1 Osteogenic factor |
| 01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
| 01/06/1993 | CN1067679A Recombinant dha-derived cholera toxin subunit analogs |
| 01/05/1993 | US5177197 Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein |
| 01/05/1993 | US5177193 In vivo half-life, genetic engineering |
| 01/05/1993 | US5177016 Monoclonal antibody recognizing anthracycline glycoside specific epitope and hybridoma secerning the antibody |
| 01/05/1993 | US5177003 Flavored protein products derived from Candida utilis |
| 01/05/1993 | US5177002 Glycosidases |
| 01/05/1993 | US5177001 In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor |
| 01/05/1993 | CA1312328C Derivative of d.25, its preparation process, its use as an immunostimulating agent and pharmaceutical compositions containing such |
| 12/30/1992 | EP0520604A2 Monoclonal antibody against pentacyclic oleanan-type triterpene and use thereof |
| 12/30/1992 | EP0520502A2 Anti-Hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
| 12/30/1992 | EP0520499A1 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 12/30/1992 | EP0520436A2 Monoclonal antibody, method of production thereof and use thereof |
| 12/30/1992 | EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor |
| 12/30/1992 | EP0124613B1 Novel plasminogen activator derived from human kidneys, process for its preparation, and thrombolytic drug containing the same |
| 12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
| 12/29/1992 | US5175278 Heteropolysaccharide S-657 |
| 12/29/1992 | US5175147 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 12/29/1992 | US5175096 Dna encoding a fibronectin binding protein as well as its preparation |
| 12/29/1992 | CA2072412A1 Monoclonal antibody, method of production thereof and use thereof |
| 12/29/1992 | CA1312031C Process for the purification of serum albumin |
| 12/29/1992 | CA1312028C Expression vectors containing the heat shock regulatory dna sequences from a heat shock protein 83 (hsp83) gene and inducible expression by use of the vectors |
| 12/29/1992 | CA1312027C Methods and compositions for expression of competent eukaryotic gene products |
| 12/29/1992 | CA1312026C Plasmid vectors for efficient expression of genes in e. coli |
| 12/29/1992 | CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas |
| 12/29/1992 | CA1312024C Process for preparing hybridoma cells which produce tumour-specific monoclonal antibodies |
| 12/28/1992 | CA2072246A1 Ccv vaccine |
| 12/24/1992 | DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria |
| 12/23/1992 | WO1992022666A1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 12/23/1992 | WO1992022665A1 Production and recovery of recombinant neurotrophins |
| 12/23/1992 | WO1992022664A1 Chemotactic factor |
| 12/23/1992 | WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 12/23/1992 | WO1992022655A1 Hepatitis c diagnostics and vaccines |
| 12/23/1992 | WO1992022653A1 Method for making humanized antibodies |
| 12/23/1992 | WO1992022652A1 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM |
| 12/23/1992 | WO1992022634A1 Production of monoclonal antibodies |
| 12/23/1992 | WO1992022584A1 Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
| 12/23/1992 | WO1992022573A1 Detection of mammalian immunodeficiency viruses |
| 12/23/1992 | WO1992022324A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands |
| 12/23/1992 | WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF |
| 12/23/1992 | WO1992017588A3 Method for production of an iga binding protein derived from group b streptococci |
| 12/23/1992 | EP0519889A2 Leydig cell stimulator |
| 12/23/1992 | EP0519866A1 Novel anti-HIV antibodies |
| 12/23/1992 | EP0519750A2 Insulin analogs |
| 12/23/1992 | EP0519728A2 Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies |
| 12/23/1992 | EP0519726A2 A process for large-scale production of antimicrobial peptide in high purity |
| 12/23/1992 | EP0519596A1 A method for reducing the immunogenicity of antibody variable domains |
| 12/23/1992 | EP0519547A2 Coccidiosis poultry vaccine |
| 12/23/1992 | EP0519469A1 Cloned glutamic acid decarboxylase |
| 12/23/1992 | EP0519218A2 Hybrid-plasmid for the 38 kDa antigen from M. tuberculosis, E. coli as host, the 38 kDa antigen and a 33 kDa protein |
| 12/23/1992 | EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
| 12/23/1992 | EP0519011A1 Protein expression via seed specific regulatory sequences |
| 12/23/1992 | EP0519008A1 Interleukin-4 binding proteins |
| 12/23/1992 | EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 12/23/1992 | EP0518999A1 Protein hydrolysates. |
| 12/23/1992 | EP0518933A1 Leukaemia inhibitory factor |
| 12/23/1992 | EP0262192B1 Method and means for producing a protein having the same igg specificity as protein g |
| 12/23/1992 | CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 12/23/1992 | CA2111110A1 Production and recovery of recombinant neurotrophins |
| 12/23/1992 | CA2111108A1 Hepatitis c diagnostics and vaccines |
| 12/23/1992 | CA2110799A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands |
| 12/22/1992 | US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3 |
| 12/22/1992 | US5173409 Recovery of bt endotoxin protein from lysed cell mixtures |
| 12/22/1992 | US5173399 Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests |
| 12/22/1992 | US5173297 Bacteriocin from lactococcus lactis subspecies lactis |
| 12/22/1992 | US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen |
| 12/22/1992 | CA2071622A1 Anti-tcf-ii monoclonal antibodies and method for the measurement of tcf-ii by applying the antibodies |
| 12/22/1992 | CA2071382A1 Insulin analogs |
| 12/22/1992 | CA1311704C Substantially purified tumor growth inhibitory factor (tif) |
| 12/22/1992 | CA1311703C Culture medium of bacteria (bordetella genum) containing etherified derivatives of d-glucose, and their application |
| 12/21/1992 | WO1993000361A1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 12/21/1992 | CA2089890A1 Prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 12/20/1992 | WO1992022639A1 ddI IMMUNOASSAYS, DERIVATIVES, CONJUGATES AND ANTIBODIES |
| 12/20/1992 | CA2088974A1 Ddi immunoassays, derivatives, conjugates and antibodies |
| 12/19/1992 | CA2071395A1 Coccidiosis poultry vaccine |
| 12/19/1992 | CA2071305A1 Anti-hiv antibodies |
| 12/19/1992 | CA2065919A1 Leydig cell stimulator |
| 12/16/1992 | EP0518757A1 Peptides or polypeptides of BVD and related viruses |
| 12/16/1992 | EP0518756A1 Procedure to detect a bovine viral diarrhoea virus infection, nucleotide sequence coding for a protein induced by infection with this virus and recombinant proteins and antigens resulting from same |
| 12/16/1992 | EP0518650A2 Sequence specific DNA binding by P53 |
| 12/16/1992 | EP0518587A2 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 12/16/1992 | EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 12/16/1992 | EP0518088A2 Process for clostripain-catalysed coupling of Arg-Pro and Arg-B (B=proteinogenic or non proteinogenic amino acids) containing them |
| 12/16/1992 | EP0517925A1 Novel megakaryocyte amplifier and production thereof |
| 12/16/1992 | EP0517918A1 Monoclonal antibody against cardiac glycoside and utilization thereof |
| 12/16/1992 | EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 12/16/1992 | EP0517853A1 METHOD FOR DETECTION OF $i(BORRELIA BURGDORFERI), PURIFIED ANTIGEN THEREOF AND ANTIBODY CAPABLE OF BINDING THEREWITH |
| 12/16/1992 | EP0517829A1 Improved chimeric toxins |
| 12/16/1992 | EP0517826A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME |
| 12/16/1992 | EP0517817A1 Inhibitors of catalytic antibodies |
| 12/16/1992 | EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |